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Abstract 
Individuals living in marginal urban housing face numerous health risks that impair 
cognition and produce burden in these individuals that may differentially attenuate 
capacity to tolerate further brain insult. We investigated the effect of self-reported 
traumatic brain injury (TBI) on cognition in persons with differential levels of 
neurocognitive burden. Two hundred and twenty participants (age: 23-68; 170 M, 50 F), 
recruited from single-room occupancy hotels underwent neurocognitive testing. A 
statistically weighted neurocognitive burden index was created reflecting the aggregate 
extent to which non-TBI comorbidities (vascular health, mental health, substance use, 
viral infection, neurological illness) and demographics (age, education, premorbid IQ) 
were associated with overall cognition. This index was investigated for its moderating 
influence on the relationship between self-reported TBI history (loss of consciousness of 
30 minutes or more) and neurocognition. Hierarchical linear regression revealed that the 
burden index accounted for 31.4% of the total variance in cognition (F(1, 212) = 97.052, 
p < .001).  TBI itself did not account for additional variance in cognition; nor did burden 
moderate the effect of TBI. Self-reported TBI history, as defined in the present study, 
has minimal value in signifying cognitive dysfunction in multimorbid marginally housed 
individuals. 
Keywords:  multimorbidity; marginalization; traumatic brain injury 
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Chapter 1. Introduction 
Residents of single-room occupancy hotels (i.e. government-owned low-income 
housing; SROs) in Vancouver make up one of the most marginalized groups in 
Canadian society (Linden, Mar, Werker, Jang, & Krausz, 2013), living in substandard 
housing that is often the only alternative to homelessness for low-income tenants (Vila-
Rodriguez et al., 2013). Individuals living in marginal urban housing face numerous 
mental and physical health risks, including substance dependence, mental illness, 
infectious disease, neurological illness or insult, and increased mortality rate (Ludwig et 
al., 2012; Patel & Burke, 2009; Shannon, Ishida, Lai, & Tyndall, 2006; Vila-Rodriguez et 
al., 2013).  
Neurologically, marginalized populations experience high rates of traumatic brain 
injury (i.e. an alteration in brain function, or other evidence of brain pathology, caused by 
an external force [TBI]; Menon, Schwab, Wright, & Maas, 2010). We recently 
characterized the physical and mental health of a large cohort of individuals living in 
SRO hotels in the Downtown Eastside of Vancouver, British Columbia (The Hotel Study; 
Vila-Rodriquez et al., 2013), and found approximately 64 percent of participants reported 
a history of head or face injury, with approximately 11 percent having definite TBI. This 
rate is consistent with that found in marginalized populations (Hwang et al., 2008), yet 
almost double the incidence proportion of individuals with TBI worldwide (i.e. 
approximately 600 per 100,000 individuals of the population; Cassidy et al., 2004). 
In marginalized populations, TBI has many cognitive, physical, and emotional 
consequences that may persist and place individuals at risk for social failure (Topolovec-
Vranic et al., 2012), with subsequent low employment rates increasing the risk of 
homelessness (van Velzen, van Bennekom, Edelaar, Sluiter, & Frings-Dresen, 2009) 
and the chronicity of remaining homeless (Backer & Howard, 2007). According to BC 
Housing, in 2001 the change in cost of health care, social services, and criminal justice 
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systems to the province of British Columbia was estimated to be approximately $30,000 
to $40,000 on average per person annually if a resident left a SRO and returned to 
homelessness (British Columbia Ministry of Social Development and Economic Security 
[BCMSDES], 2001). In a 2006 study, this number rose to an estimated $55,000 per 
person annually (Patterson, Somers, McIntosh, Shiell, & Frankish, 2008). Understanding 
the effects of TBI in marginally housed persons has the potential to reduce the number 
of individuals that will face negative outcomes, including homelessness. This will provide 
significant financial, societal, and individual implications (Topolovec-Vranic et al., 2012).  
Although acute deficits in cognition can be found at all severities of TBI (i.e. mild, 
moderate, severe), there is a dose-response relationship between the length of 
unconsciousness following a TBI and the level of performance on neuropsychological 
measures at one year post-injury (Dikmen, Machamer, Winn, & Temkin, 1995). A 
systematic review of meta-analyses on the cognitive sequelae of mild TBI by Karr, 
Areshenkoff, and Garcia-Barrera (2014) showed that overall cognitive functioning 
recovery following mild TBIs (i.e. head injuries that result in a loss of consciousness for 
30 minutes or less; Kay et al., 1993) occurred within 90 days post-injury for most 
individuals. Those with mild TBI have been found to be comparable to controls on 
measures of cognition at three months (Frencham, Fox, & Mayberry, 2005) and one year 
(Dikmen et al., 1995) post-injury. Single-incident mild TBI has been found to have little 
clinical significance to long-term cognitive and symptom outcome (Ettenhofer & Abeles, 
2009). Following moderate to severe TBI (i.e. head injury that result in a loss of 
consciousness for more than 30 minutes; Kay et al. 1993), cognition improves during the 
first two years, but remains impaired even among patients assessed more than two 
years post-injury. Averaged across all follow-up periods, the effect of moderate and 
severe TBI in individuals with low levels of multimorbidity was more than three times the 
effect of mild TBI on overall cognitive functioning (Schretlen & Shapiro, 2003).  
In otherwise high functioning individuals, moderate to severe TBIs cause 
cognitive deficits predominantly in the areas of attention, processing speed, and verbal 
learning and memory (Fleminger, 2008; Griffen, & Hanks, 2014; Hopkins, Tate, & Bigler, 
2005; Mathias & Wheaton, 2007; Miotto et al., 2010). A single moderate to severe TBI 
has been found to have negative implications for the brain and cognition with advanced 
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age, suggesting interplay between early head trauma and the aging process (Ozen, 
Fernandes, Clark, & Roy, 2015). Those with a history of moderate to severe TBI also 
have an increased risk of developing Alzheimer’s disease (Plassman et al., 2000).  
Although much is known about the effects of TBI on cognition in the general 
population, more research is needed to understand its impact in marginalized persons 
(Hwang et al., 2008). Interpreting and predicting cognitive deficits after traumatic brain 
injury in persons living in SROs may be difficult due to the many potential interacting 
factors that can influence it. The multitude of risk factors that marginalized populations 
face across the lifespan (e.g. developmental, substance use, viral infection, psychiatric 
illness, and brain injury) is apt to impose a substantial neurocognitive burden (Gicas et 
al., 2014), making individuals less able to deal with further brain insult. One risk factor for 
neurocognitive burden is captured in the comprehensive theories of brain (Satz, 1993) 
and cognitive (Stern, 2002) reserve. Reserve theories attempt to explain individual 
differences in functional outcome following brain insult (Kesler, Adams, Blasey, & Bigler, 
2003), based on the repeated observation that there does not appear to be a direct 
relationship between the degree of brain damage and the clinical manifestation of that 
damage (Stern, 2002).  
Although models of reserve have been supported in research on brain injury 
outcomes, low cognitive reserve may be only one possible risk factor for neurocognitive 
burden. Nunnari, Bramanti, and Marino (2014) note that the current literature has 
focused on only a targeted subset of risk factors for neurocognitive burden in individuals 
with TBI (i.e. education, premorbid IQ). TBI is thought to have a synergistic deleterious 
impact on cognition by interacting with many other risk factors for neurocognitive burden 
to produce poor brain health and functional outcomes (Monti et al., 2013; Moretti et al., 
2012). For instance, compared to those with TBI alone, additional neurocognitive deficits 
have been found in persons with TBI and substance abuse (Corrigan, 1995). In a study 
by Kelly, Johnson, Knoller, Drubach, and Winslow (1997), neuropsychological outcome 
was examined in severe traumatic brain injury patients who were drug users, alcohol 
users, or neither. Following acute recovery, non-alcohol or drug using patients with TBI 
performed significantly better than both alcohol and drug users on composite and verbal 
intelligence, as well as measures of general and verbal memory, attention and 
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concentration. Similarly, a study by Dikmen, Donovan, Løberg, Machamer, and Temkin 
(1993) found that neuropsychological impairment following mild to severe head injury 
was related both to the severity of injury and preinjury alcohol abuse. In individuals with 
mild to moderate TBI, additional neurocognitive deficits have also been found in persons 
with comorbid depression (Chamelian & Feinstein, 2006). Midlife cardiovascular health 
has been associated with cognitive decline at six (Knopman et al., 2001) and 20 years 
later (Virta et al., 2013), as well as late life dementia (Whitmer, Sidney, Selby, Claiborne 
Johnston, & Yaffe, 2005). Cognitive impairment has been associated with psychotic 
disorders (Heinrichs & Zakzanis, 1998), viral infection (Dieperink, Willenbring, & Ho, 
2000; Reger, Welsh, Razani, Martin, & Boone, 2002), and neurological illness or insult 
(Vermeer et al., 2003).  
Given the ubiquity of multiple comorbid risk factors among marginally housed 
persons with a history of head injury, greater clarity of the relative impact of these risk 
factors, both individually and in aggregate, on cognition is of value. Rather than a simple 
linear relationship between TBI and cognition in marginalized populations, there is likely 
to be a complex process influenced by both acquired and inherited neuroprotective 
factors, and factors that increase the neurocognitive burden on the brain, causing or 
predisposing persons to negative outcomes (Mesulam, 2000; Fotuhi, Hachinski, & 
Whitehouse, 2009).  
To explore the complex interactions of multiple co-morbid factors on cognitive 
dysfunction in marginalized persons with TBI, this study will examine the effect of self-
reported moderate to severe traumatic brain injury on cognition in persons with 
differential levels of neurocognitive burden, since those with history of mild TBI are not 
expected to have lasting impairments. Better understanding of the various processes 
that can add to one’s level of neurocognitive burden, impacting brain and cognitive 
health, is crucial in understanding individual differences in functioning following TBI. 
Furthermore, understanding the impact of specific risk factors for neurocognitive burden 
on cognition will identify the most influential treatment foci (e.g. vascular health versus 
mental illness) in multimorbid marginalized populations. The main objective of this study 
is to create a neurocognitive burden index to determine: 
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1. If certain risk factors for neurocognitive burden differentially predict cognition. 
2. The potential aggregate impact of multimorbid risk factors for neurocognitive 
burden on cognition. 
3. The potential association between TBI and cognition after controlling for level 
of neurocognitive burden. 
4. If the level of neurocognitive burden moderates the effect of TBI on cognition. 
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Chapter 2. Methods 
2.1. Participants 
Three hundred seventy four participants were recruited from the downtown 
eastside of Vancouver. Participants were recruited by approaching all tenants within four 
single room occupancy hotels in the area. Participation was voluntary, with honorarium 
given. All participants had adequate English language fluency for the purpose of valid 
psychometric testing. Of the individuals approached (N=406), 92% (N=374) provided 
informed consent to communicate clinically signiﬁcant ﬁndings to the participants’ 
physicians. The final sample was reduced to 220, after excluding those with 
missing/invalid cognitive or injury data or magnetic resonance image (MRI) scans (used 
to objectively verify self-report from non-TBI controls; see Appendix A for participant flow 
chart). The participants (170 M, 50 female) had an age range of 23 to 68 years (mean 
age = 43 yrs). The sample was 59% Caucasian, 28% Aboriginal, 3% Asian, 2% African 
American, and 8% mixed/other ethnicities. Sixty percent of participants did not complete 
high school, 37% completed high school, and 3% completed a college or university 
program. The average monthly income was $887 CDN, with 8% of participants earning 
an income with benefits. There was ubiquitous substance dependence (95%), with 61% 
engaged in injection drug use. Viral infection was present in 70% of participants, and 
22% of participants have a history of self-reported acquired TBI (moderate to severe). 
These characteristics make this sample appropriate for the study of individuals with 
multiple comorbidities. Table 1 presents frequencies of demographic and clinical 
characteristics of the final sample and pre-sampling population. 
Table 1. Final Sample Characteristics Compared to Pre-Sampling Population 
(i.e. all those entered into the study, including those excluded in the 
analyses) 
 Study Sample  Pre-sampling Population 
Clinical Characteristic Total N N %  Total N N % 
 7 
 Study Sample  Pre-sampling Population 
Clinical Characteristic Total N N %  Total N N % 
Drug Dependence 
     Alcohol 220 35 15.9  371 67 18.1 
     Cocaine 220 157 71.4  371 253 68.2 
     Methamphetamine 220 56 25.5  371 93 25.1 
     Heroin 220 83 37.7  371 137 36.9 
     Other Opiate 220 45 20.5  371 72 19.4 
     Methadone 220 92 41.8  371 146 39.4 
     Cannabis 220 68 30.9  371 115 31.0 
Mental Illness 
     Psychotic illness, any 220 104 47.3  371 175 47.2 
     Depression 220 34 15.5  371 54 14.6 
Viral Infection 
     HIV 220 33 15.0  356 61 17.1 
     HepB 220 82 37.3  354 143 40.4 
     HCV (cleared/active) 208 138 66.3  338 226 66.9 
     Cytomegalovirus 220 146 66.4  353 236 66.9 
     Herpes Simplex Virus 219 194 88.6  253 314 89.0 
Vascular Health 
     History of stroke 219 11 5.0  348 16 4.6 
     High Cholesterol 218 41 18.8  339 62 18.3 
     Heart Attack/Disease 219 21 9.6  348 34 9.8 
     Diabetes 219 9 4.1  348 14 4.0 
     BMI Obese 217 13 6.0  361 26 7.2 
Neurological Illness/Insult 
     Movement disorder 215 35 16.3  337 63 18.7 
     Infarct 220 11 5.0  290 15 5.2 
     Lacune 219 10 4.6  289 15 5.2 
     Stroke 220 22 10.0  290 30 10.3 
          Stroke with Hemorrhage 219 3 1.4  371 3 0.8 
Traumatic Brain Injury 
     Moderate to Severe TBI 220 49 22.3  287 49 17.1 
          TBI as defined by MRI  220 8 3.6  287 21 7.3 
          Penetrating TBI 220 0 0  372 2 0.5 
Clinical cognitive impairment 220 11 5.0  371 32 8.6 
Note.  HIV = human immunodeficiency virus;  HepB = hepatitis B virus;  HCV = hepatitis C virus;  BMI = 
body mass index;  MRI = magnetic resonance imagine. 
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2.2. Procedures 
Cognitive testing was conducted by trained research assistants. To ensure 
standardization, reports were made of the subjective validity of each assessment and 
the occurrence of any outstanding events. Demographic information, premorbid 
intelligence (IQ), viral infection, mental health, substance dependence (i.e. substances 
used, amount, frequency of use), and self-reported histories of TBI were collected. 
Cognition was assessed using a comprehensive neuropsychological battery. High-field 
magnetic resonance images were collected to ascertain multi-modal in-vivo structural 
brain data. Each full data assessment lasted approximately 5 hours.  
2.3. Measures Used 
2.3.1. Traumatic brain injury measures.  
Participants completed an interviewer administered medical review form (MRQ; see 
Appendix B question 8 for more details regarding relevant questions), a 17-item 
questionnaire assessing previous medical history and current medical conditions. 
Participants were asked about the occurrence of any previous head or face injuries. 
Those with a history of injury in this area were further asked to describe their age at the 
time of the injury, the event that caused the injury, the injury itself, the length of any 
memory loss and loss of consciousness, and any hospitalizations for the injury. 
Participants were asked if they experienced a variety of common neuropsychological 
complaints after acquired TBI, and for how long these occurred. 
2.3.2. Risk factors for neurocognitive burden measures. 
Cognitive reserve. Demographic information was obtained using a 
standardized form that asked participants to report their age, gender, ethnicity, number 
of years of education completed, and average monthly income. Premorbid IQ was 
assessed by the Wechsler Test of Adult Reading (WTAR; Wechsler, 2001). The WTAR 
is an estimate of an individual’s level of IQ before the onset of illness or injury (i.e. TBI). 
Participants were presented with 50 atypical words and asked to read each aloud. Total 
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scores range from 0 to 50, measuring the number of correctly read words. This measure 
has been found to have high stability during recovery from TBI (r = .97) and convergent 
validity with demographic estimates of premorbid IQ at both two (r = .54) and five (r = 
.58) months post injury (Green et al., 2008). As reported in recent studies, cognitive 
reserve was calculated as a standardized composite of years of education attained and 
premorbid IQ (i.e. reading ability (Brickman et al., 2011; Patel et al., 2013; Rentz et al., 
2010).  
Vascular Health. Participants were assessed for a range of risk factors for 
poor vascular health, including history of heart attack or heart disease, history of stroke, 
diabetes, high cholesterol, high blood pressure, and obesity. 
History of heart attack/disease, history of stroke, and diabetes. 
Participants self-reported if they had ever experienced a stroke, heart attack or heart 
disease, or diabetes via an interviewer-administered medical review questionnaire. Of 
those with self-reported history of stoke, 18% showed evidence of stroke on MRI or were 
currently on related doctor prescribed medication. Of those with a history of heart attack 
or disease, 9% are currently on related doctor prescribed medication. Of those with self-
reported diabetes, 67% are currently on doctor prescribed medication to manage 
diabetes or showed average blood sugar levels in the diabetic range according to blood 
work (i.e. 6.5 % or higher of glycated hemoglobin). 
Cholesterol. Blood testing of all participants was done at the BC Centre for 
Disease Control. Participants were coded at having optimum levels (i.e. less than or 
equal to 5 mmol) or mild to very high level (i.e. greater than 5 mmol) of cholesterol.  
Pulse pressure. A calculation (i.e. systolic [minus] diastolic blood pressure) 
was done for all participants based off an average of three blood pressure 
measurements. All individuals with abnormal levels of pulse pressure (i.e. 60 or higher) 
were on doctor prescribed medication for hypertension.  
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Obesity. Body mass index was calculated based off of measurements of 
participant height and weight (i.e. BMI = kg/m2, where kg as weight in kilograms and 
m2 as height in metres squared).  
Substance dependence. Drug (i.e. alcohol, cocaine, methamphetamine, 
heroin, methadone, cannabis) dependence was diagnosed through psychiatric interview 
according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text 
revision; DSM-IV-TR; American Psychiatric Association, 2000) in consensus with the 
Best Estimate Clinical Evaluation and Diagnosis 2 (BECED-II; Endicott, 1988). The best 
estimate procedure has been found to be optimal in studies investigating a broad range 
of disorders, where the use of drugs is not an exclusion criterion (Fennig, Craig, Lavelle, 
Kovasznay, & Bromet, 1994). 
Mental illness. Mental disorders were diagnosed through psychiatric interview 
according to the DSM-IV-TR criteria in consensus with the BECED-II. 
Viral infection. Blood samples underwent serology testing at the BC Centre for 
Disease Control for antibodies to the human immunodeficiency virus (HIV), hepatitis B, 
hepatitis C, herpes simplex, and cytomegalovirus. This method has been found to have 
strong sensitivity in detecting recent infections (89%), specificity in detecting established 
infections within the first year of transmission (86.8%), and specificity in detecting 
infections of durations longer than one year (98%; Guy et al., 2009). 
Neurological insult or illness. Diagnoses were made with anatomic MRI, 
with scans reviewed by a neuroradiologist. Relevant diagnoses included cerebral 
infarcts, lacunes, non-TBI encephalomalacia, stroke with hemorrhage, hemorrhage not 
due to stoke, possible multiple sclerosis, and non-TBI lesions/trauma (e.g. due to 
infection). 
2.3.3. Dependent Measures. 
Cognition. Verbal learning and memory, working memory, and selective and 
sustained attention were assessed. These domains of cognition have been found to be 
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sensitive to the effects of traumatic brain injury on cognition (Dikmen et al., 1995). All 
three cognitive measures were significantly correlated with each other (i.e. r > .3, p < 
.001), and were subsequently combined into a standardized cognitive composite score. 
Verbal learning and memory. Participants completed the Hopkins Verbal 
Learning Test – Revised (HVLT-R; Brandt, 1991), where trials of 12 words are orally 
presented and participants are assessed for immediate and delayed recall, and delayed 
recognition. This measure has been shown to have adequate construct, concurrent, and 
divergent validity (Shapiro, Benedict, Schretlen, & Brandt, 1999).  
Selective attention. Participants completed the Stroop Color and Word Test 
(Golden, 1978), where a list of colour words printed in a conflicting colour (e.g. “green” 
printed in blue ink) are presented and participants are asked to identify the ink colour as 
quickly as possible within a time limit. This measure has been found to have high 
reliability and a valid test of attention and executive functioning in both normal humans 
and those with neuropsychological impairments (MacLeod, 1991).  
Sustained attention and working memory. Participants completed the Rapid 
Visual Information Processing (RVP) subtest of the Cambridge Neuropsychological Test 
Automated Battery (CANTAB; Cambridge Cognition, 2002). The RVP is a computer-
administered nonverbal task designed to assess sustained attention where participants 
are presented with a series of pseudo-random ordered numbers and tested on their 
ability to detect target sequences of digits (e.g. 2-4-6) by responding using a press pad. 
The CANTAB has been found to be sensitive to frontal lobe dysfunction and differences 
in executive functioning in adults (Robbins et al., 1994; Robbins et al., 1998), and 
modestly associated with traditional neuropsychological measures (Smith, Need, Cirulli, 
Chiba-Falek, & Attix, 2013). 
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Chapter 3. Analysis 
3.1. Design 
Operational definitions of TBI and comparator group. Two groups 
were included in the design: multimorbid, poly-substance abusing individuals who have 
1) self-reported a previously acquired moderate to severe TBI (i.e. head injury that 
resulted in unconsciousness for more than 30 minutes or post-traumatic amnesia for 
more than 24 hours) with or without MRI verified TBI, since mild TBI has been found to 
have little clinical significance to long-term cognitive and symptom outcome (Ettenhofer 
& Abeles, 2009), and 2) non-TBI controls with no MRI verified history of traumatic brain 
injury, and either no reported head/face trauma or head/face trauma with no 
hospitalization, loss of consciousness, confusion or loss of memory, dizziness, 
headache, blurred vision, or other problems relating to the injury. Those who were 
unsure as to whether they had acquired a head/face injury were included in the nTBI 
group as they did not differ from the controls on cognition, demographics, clinical 
characteristics or MRI verification status. To ensure that we had a clean sample of non-
TBI controls, those with a reported head/face injury with an unknown amount of 
unconsciousness or post-traumatic amnesia, a mild TBI (i.e. a head injury with a loss of 
consciousness of 30 minutes or less or post-traumatic amnesia of 24 hours or less), or 
no reported head/face injury but a TBI as verified by MRI, were excluded. These 
definitions of TBI severity are consistent with standardized consensus criteria (Kay et al., 
1993). A validity check was done to test the convergence between TBI classification 
based on the MRQ and that done on a subset of individuals using the Brain Injury 
Screening Questionnaire. To examine the validity of self-reported traumatic brain injury 
in this sample, the effect of objective TBI (i.e. TBI as determined by MRI alone) on 
cognition was examined. 
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Statistical Approach. To create a neurocognitive burden index, an 
approach derived by Patel et al.’s (2013) study examining the aggregate effect of 
multiple comorbid risk factors in cognition among HIV-infected individuals was used. 
First, TBI and all risk factors for neurocognitive burden were screened for their individual 
impact on composite cognition. To include all variables associated with deficits in 
cognition, variables with a small effect size (d = .2; Cohen, 1992) or higher in the 
appropriate direction (i.e. negatively associated with cognition) were included in the 
index, while all other variables were dropped (see Appendix C for list of all independent 
measures, descriptions, effect sizes, and coding for inclusion in neurocognitive burden 
index). Included risk factors were then weighted based on their unstandardized beta 
coefficients, and then combined to create the neurocognitive burden index. This was 
done by saving the unstandardized predicted value from the regression.  
Subsequently, hierarchical regression using the neurocognitive burden index 
assessed the aggregate impact of multimorbid risk factors on cognition, the association 
between TBI and cognition (controlling for level of burden), and the extent to which 
burden moderates the effect of TBI in its impact on cognition. Finally, hierarchical 
regression analyses were conducted to determine 1) the effects of neurocognitive 
burden and TBI on individual cognitive domains (i.e. verbal learning and memory, 
selective attention, and sustained attention and working memory); and 2) the extent to 
which aspects of neurocognitive burden (e.g. age, mental illness) and TBI predict 
cognition.  
3.2. Data Diagnostics 
Descriptive statistics were examined for all variables on measures central 
tendency (i.e. mean, median, and mode), as well as the distribution of scores (i.e. 
minimum, maximum, range, standard deviation, skewness, and kurtosis). An initial 
inspection of the minimum and maximum values, along with a histogram of each variable 
data, was done to check for floor effects and possible outliers. Table 2 presents 
descriptive statistics for each individual cognitive measure, indicating that there were no 
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floor effects observed in any area of cognition. See Figure 1 for frequency tables of each 
individual cognitive measure.  
Table 2 Descriptive Statistics of Each Individual Cognitive Measure (N = 220) 
 Cognitive Measure 
Statistic HVLT imm Stroop CW RVP  
     M 19.168 35.429 .863  
     SD 5.638 9.827 .059  
     Skewness -.177 .259 -.325  
     Kurtosis -.464 .091 .462  
     Range 27 52 .34  
     Minimum 4 13 .66  
     Maximum 31 65 1  
Note.  HVLT imm = Hopkins Verbal Learning Test immediate recall;  Stroop CW = Stroop Color and Word 
Test interference;  RVP = Rapid Visual Information Processing;  NBI = neurocognitive burden index;  TBI = 
traumatic brain injury. 
*p < .05.    **p < .01.    *** p < .001. 
 
Figure 1 Frequency tables of each cognitive measure indicating no floor or 
ceiling effects. 
Data points with absolute-value z-scores greater than 3.29 were considered 
outliers. Valid scores were adjusted to one unit above of the highest non-outlying value 
(Tabachnick, 2001). Multicollinearity was assessed by examining the variance inflation 
factor, with a cut-off of 5 or higher indicating possible multicollinearity. Table 3 presents 
correlation coefficient values between all possible predictor variables. The assumption 
that the model correctly specified all relevant predictors and the form of the relationship 
between predictors and the criterion was checked by inspecting the scatterplot of 
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residuals to predicted values. Homoscedasticity of errors was assessed by examining 
the variance in residuals at each estimated value of cognition. Normality of errors was 
assessed with Normal Q-Q Plots of residuals. Fixed factors were checked with 
Cronbach’s alpha ≥7 (Taylor, 1990). The independence of errors were checked with a 
Durbin-Watson test of lag 1 autocorrelation. 
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Table 3 Correlation Coefficient Values (Spearman’s Rho) Between Predictor Variables (N = 220) 
Predictor 1 2 3 4 5 6 7 8 9 10 11 
TBI (1) 
Cognitive reserve (2) .077 
Schizophrenia (3) -.093 -.033 
Age (4) .110 -.054 -.192** 
Psychosis NOS (5) .086 .161* -.103 -.012 
Heart attack/ disease 
(6) 
.015 -.011 -.103 .055 -.103 
Stroke with 
hemorrhage (7) 
.033 -.109 -.037 .073 -.038 -.039 
Non-TBI brain 
lesion/trauma (8) 
.127 -.043 -.037 .043 .095 -.039 -.014 
HIV (9) .020 .040 -.044 .085 .080 .123 .062 -.049 
Diabetes (10) -.054 .030 .014 .206** -.066 .245*** -.025 -.025 .041 
Hepatitis B (11) .062 .222** -.178** .277*** .102 -.060 .072 -.009 .176** -.018 
Brain Lacunes (12) .040 .331 -.067 .171* .152* .003 -.026 -.026 -.031 .065 .057 
Note.  TBI = traumatic brain injury;  NOS = not otherwise specified;  HIV = human immunodeficiency virus. 
*p < .05.    **p < .01.    *** p < .001.
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3.3. Power 
A power profile calculation was conducted using G*Power 3.1 (Faul, Erdfelder, 
Buchner, & Lang, 2009), which indicated a strong power profile. For 11 predictors (i.e. all 
risk factors for neurocognitive burden), a sample size of 220, alpha of 0.05, and a low 
observed R2 of 0.1, the observed statistical power is 0.93.  
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Chapter 4. Results 
As anticipated, a simultaneous linear regression revealed that risk factors for 
neurocognitive burden differentially predicted composite cognition. Table 4 displays the 
unstandardized regression coefficients (B), the standard error of B (SE B), and the 
standardized regression coefficients (β) after entry of all 11 predictors. The R2 value of 
.312 indicates that more than a third of the variance in cognition was accounted for by 
cognitive reserve, schizophrenia, age, and psychosis not otherwise specified. History of 
heart attack or disease, diabetes, HIV, hepatitis B, non-TBI brain lesions or trauma, 
stroke with hemorrhage, or brain lacunes did not significantly predict composite 
cognition. 
Table 4 Summary of Simultaneous Regression Analyses for Risk Factors for 
Neurocognitive Burden Predicting Composite Cognition (N = 220) 
Composite Cognition 
Predictor B SE B β 
Cognitive reserve -.401 .061 -.402*** 
Schizophrenia -1.007 .210 -.290*** 
Age -.245 .064 -.245*** 
Psychosis NOS -.465 .207 -.137* 
Heart attack/disease -.400 .208 -.118 
Stroke with hemorrhage -.610 .506 -.071 
Non-TBI brain lesion/trauma -.429 .504 -.050 
HIV -.128 .168 -.046 
Diabetes -.156 .310 -.031 
Hepatitis B -.052 .133 -.025 
Brain Lacunes .049 .287 .010 
R2 .312 
F 8.416*** 
Note.  NOS = not otherwise specified;  HIV = human immunodeficiency virus. 
*p < .05.    **p < .01.    *** p < .001.
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Next, a hierarchical regression was employed using the neurocognitive burden 
index created in the initial regression (Block 1), history of TBI (Block 2), and their 
interaction (Block 3), as predictors of composite cognition. Table 5 displays the 
unstandardized regression coefficients (B), the standard error of B (SE B), and the 
standardized regression coefficients (β) for each predictor. The neurocognitive burden 
index accounted for 31.4% of the variance in composite cognition, indicating a significant 
aggregate impact of multiple comorbid risk factors on cognition. Traumatic brain injury 
did not account for a significant amount of additional variance in composite cognition, 
after controlling for level of neurocognitive burden. Similarly, level of neurocognitive 
burden was not found to moderate the relationship between TBI and cognition as the 
interaction was not significant (see below). Thus, contrary to the prediction, TBI was not 
a significant predictor of cognition regardless of level of neurocognitive burden. 
Table 5 Summary of Hierarchical Regression Analyses for Neurocognitive 
Burden Index and Traumatic Brain Injury Predicting Composite 
Cognition (N = 220) 
Composite Cognition 
Predictor B SE B β 
Block 1 
     Neurocognitive burden index -1.002 .102 -.560*** 
R2 .314 
F Change 97.052*** 
Block 2 
     Neurocognitive burden index -1.013 .102 -.566*** 
     Traumatic brain injury .149 .137 .062 
R2 .318 
F Change 1.190 
Block 3 
     Neurocognitive burden index -.988 .115 -.553*** 
     Traumatic brain injury .158 .138 .066 
     NBI × TBI interaction -.115 .252 -.030 
R2 .319 
F Change .210 
Note.  NBI = neurocognitive burden index;  TBI = traumatic brain injury. 
*p < .05.    **p < .01.    *** p < .001.
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Exploratory 1. Separate exploratory hierarchical regression analyses were
conducted to determine whether level of neurocognitive burden (Block 1), traumatic 
brain injury (Block 2), and their interaction (Block 3) predicted the individual cognitive 
domains of verbal learning and memory (i.e. HVLT), selective attention (i.e. Stroop CW), 
and sustained attention and working memory (i.e. RVP). Table 6 displays the 
unstandardized regression coefficients (B), the standard error of B (SE B), and the 
standardized regression coefficients (β), squared Pearson correlation coefficient (R2), F 
statistics for the change in R2 (F) and for each predictor.  
Similar to the composite results, level of neurocognitive burden was a significant 
predictor of performance in all three cognitive domains, accounting for 19.2, 20.8, and 
16.9% of the variance in verbal learning in memory, selective attention, and sustained 
attention and working memory, respectively. Consistent with performance on composite 
cognition, traumatic brain injury and the neurocognitive burden by TBI interaction did not 
accounted for a significant amount of variance in any cognitive domain. Thus, traumatic 
brain injury was not a significant predictor of any individual cognitive domain regardless 
of level of neurocognitive burden. 
Table 6 Summary of Hierarchical Regression Analyses for Neurocognitive 
Burden Index and Traumatic Brain Injury Predicting Each Cognitive 
Measure (N = 220) 
Cognitive Measure 
Predictor HVLT imm Stroop CW RVP 
Neurocognitive burden index 
     B -7.852 -7.612 -.042 
     SE B 1.282 1.204 .007 
     β -.436*** -.439*** -.417*** 
     R2 .192 .208 .169 
     F Change 49.052*** 54.465*** 39.419*** 
Traumatic brain injury 
     B .962 .923 .009 
     SE B 1.539 1.459 .009 
     β .040 .040 .066 
     R2 .194 .209 .173 
     F Change .369 .307 .993 
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Cognitive Measure 
Predictor HVLT imm Stroop CW RVP 
NBI × TBI interaction 
     B -.520 -1.866 .000 
     SE B 2.803 2.758 .016 
     β -.013 -.048 -.001 
     R2 .194 .211 .173 
     F Change .034 .468 .000 
Note.  HVLT imm = Hopkins Verbal Learning Test immediate recall;  Stroop CW = Stroop Color 
and Word Test interference;  RVP = Rapid Visual Information Processing;  NBI = neurocognitive 
burden index;  TBI = traumatic brain injury. 
*p < .05.    **p < .01.    *** p < .001.
Exploratory 2. A simultaneous linear regression was conducted to
compare the extent to which aspects of neurocognitive burden (i.e. age, cognitive 
reserve, mental illness, viral infection, vascular health, neurological illness) and TBI 
predict cognition. Table 7 displays the unstandardized regression coefficients (B), the 
standard error of B (SE B), and the standardized regression coefficients (β) after entry of 
all seven predictors. In order of highest to lowest predictive power, cognitive reserve (i.e. 
composite of education and premorbid intelligence), mental illness (i.e. composite of 
schizophrenia and psychosis not otherwise specified), age, and vascular health (i.e. 
composite of history of diabetes, and heart attack/disease) were significant predictors of 
composite cognition. The R2 value of .296 indicates that close to one third of the 
variance in cognition (26.9% shared, 2.7% unique) was accounted for by these four 
aspects of neurocognitive burden. Viral infection (i.e. composite of HIV and hepatitis B), 
neurological illness (i.e. composite of presence of brain lacunes, non-TBI lesion/trauma, 
and stroke with hemorrhage), and traumatic brain injury were not significant predictors of 
cognition. 
Table 7 Summary of Simultaneous Regression Analyses for Domains of 
Risk Factors for Neurocognitive Burden Predicting Composite 
Cognition (N = 220) 
Composite Cognition 
Predictor B SE B β sr2 
Cognitive reserve -.379 .060 -.379*** -.135 
Mental illness -.714 .153 -.279*** .074 
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Composite Cognition 
Predictor B SE B β sr2 
Age -.229 .063 -.229*** .045 
Vascular health -.318 .151 -.126* .015 
Viral infection -.070 .095 -.046 .002 
Neurological illness -.124 .229 -.032 .001 
Traumatic brain injury .156 .142 .065 .004 
R2 .296 
F 12.431*** 
Note.  sr2 = the squared semipartial correlation which indicates the unique variance predicted by the 
independent variable. 
*p < .05.    **p < .01.    *** p < .001.
Validity of self-reported TBI. TBI classification based on the Medical
Review Questionnaire was found to have fair agreement with that done on a subset of 
individuals (N=54) using the Brain Injury Screening Questionnaire (BISQ), K = .281 (96% 
hits, 65% misses; Landis & Koch, 1977). A hierarchical regression analysis was rerun 
(i.e. neurocognitive burden in Block 1, history of TBI in Block 2, interaction term Block 3) 
using the BISQ to classify those with TBI from controls. Table 8 displays the 
unstandardized regression coefficients (B), the standard error of B (SE B), and the 
standardized regression coefficients (β) for predictors of composite cognition when TBI 
is defined both according to the MRQ (as reported in Table 5) and the BISQ. Results 
were consistent whether traumatic brain injury was defined according to the MRQ or the 
BISQ. Regardless, while the neurocognitive burden index was a significant predictor of 
cognition, traumatic brain injury did not account for a significant amount of variance in 
composite cognition, after controlling for level of neurocognitive burden. Level of 
neurocognitive burden was again did not moderate the relationship between TBI and 
cognition. Thus, traumatic brain injury was not a significant predictor of cognition, 
regardless of level of neurocognitive burden or whether TBI was defined according to the 
MRQ or BISQ. 
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Table 8 Summary Comparison of Hierarchical Regression Analyses for 
Neurocognitive Burden Index and Traumatic Brain Injury as Defined 
by MRQ (N = 220) and BISQ (N = 54) Predicting Composite Cognition 
Composite Cognition 
Predictor B SE B β 
MRQ defined TBI 
     Neurocognitive burden index -.988 .115 -.553*** 
     Traumatic brain injury .158 .138 .066 
     NBI × TBI interaction -.115 .252 -.030 
R2 .319 
F Change .210 
BISQ defined TBI 
     Neurocognitive burden index -.849 .394 -.475* 
     Traumatic brain injury -.019 .219 -.009 
     NBI × TBI interaction -.204 .469 -.095 
R2 .316 
F Change .190 
Note.  MRQ = Medical Review Questionnaire;  BISQ = Brain Injury Screening Questionnaire;  NBI = 
neurocognitive burden index;  TBI = traumatic brain injury. 
*p < .05.    **p < .01.    *** p < .001.
To further examine the validity of self-reported traumatic brain injury in this 
sample, the effect of objective TBI (i.e. TBI as determined by MRI alone) on cognition 
was examined. Hierarchical linear regression was rerun (i.e. neurocognitive burden 
index in Block 1, history of TBI in Block 2, interaction term in Block 3), using MRI defined 
TBI as predictors of composite cognition. Table 9 displays the unstandardized 
regression coefficients (B), the standard error of B (SE B), and the standardized 
regression coefficients (β) for predictors of composite cognition when TBI is objectively 
defined by MRI. Again, results were consistent with that found with self-reported TBI. 
The neurocognitive burden index was a significant predictor of cognition, accounting for 
31.4% of the variance. MRI defined traumatic brain injury did not accounted for a 
significant amount of variance in composite cognition, after controlling for level of 
neurocognitive burden.  Again, the neurocognitive burden index did not moderate the 
relationship between TBI and cognition. Thus, similar to that found with multiple 
24 
measures of self-reported TBI, objectively defined traumatic brain injury was not a 
significant predictor of cognition regardless of level of neurocognitive burden. 
Table 9 Summary of Hierarchical Regression Analyses for Neurocognitive 
Burden Index and Objective Traumatic Brain Injury Predicting 
Composite Cognition (N = 220) 
Composite Cognition 
Predictor B SE B β 
Block 1 
     Neurocognitive burden index -1.002 .102 -.560*** 
R2 .314 
F Change 97.052*** 
Block 2 
     Neurocognitive burden index -.990 .103 -.554*** 
     Traumatic brain injury .215 .307 -.040 
R2 .316 
F Change .489 
Block 2 
     Neurocognitive burden index -1.017 .106 -.569*** 
     Traumatic brain injury -.457 .317 -.086 
     NBI × TBI interaction -.569 .490 .083 
R2 .320 
F Change 1.349 
Note.  NBI = neurocognitive burden index;  TBI = traumatic brain injury. 
*p < .05.    **p < .01.    *** p < .001.
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Chapter 5. DISCUSSION 
The main objectives of this study were to create an index to examine the 
independent and aggregate impact of various multimorbid risk factors for neurocognitive 
burden on cognitive functioning, as well as the impact of traumatic brain injury on 
neurocognition in individuals with varying levels of neurocognitive burden. Although 
much is known about the effects of TBI on cognition in the general population, more 
research is needed to understand its impact in marginalized persons (Hwang et al., 
2008).  Rather than a simple linear relationship between TBI and cognition in 
marginalized populations, there is likely to be a complex process influenced by both 
acquired and inherited neuroprotective factors, and factors that increase the 
neurocognitive burden on the brain, causing or predisposing persons to negative 
outcomes (Mesulam, 2000; Fotuhi, Hachinski, & Whitehouse, 2009). Given the ubiquity 
of multiple comorbid risk factors among marginally housed persons with a history of 
head injury, greater clarity of the relative impact of these risk factors, both individually 
and in aggregate, on cognition is necessary. 
5.1. Pattern of Findings 
As expected, initial analyses revealed that many multimorbid risk factors for 
neurocognitive burden predicted neurocognitive functioning in this marginally housed 
sample. Cognitive reserve, defined by education and premorbid intelligence, appeared to 
be the strongest predictor of composite cognitive functioning. Other significant predictors 
of cognition, in order of influence, were schizophrenia, older age, and psychosis not 
otherwise specified. Individual indices of vascular health, including diabetes and history 
of heart attack or heart disease, were not significant predictors of neurocognition. Viral 
infections, including HIV and hepatitis B, were also not found to be associated with 
cognition. Lastly, MRI defined brain lesions or trauma due to infection, stroke with 
hemorrhage, or brain lacunes did not predict cognitive functioning. 
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Due to the manner in which the neurocognitive burden index was created, it is 
unsurprising that there was a main effect of burden on cognition. Level of neurocognitive 
burden predicted differential composite neurocognitive functioning, such that individuals 
with higher levels of neurocognitive burden (due to multiple factors including older age, 
lower cognitive reserve, poor vascular health, and the presence of mental and 
neurological illness) demonstrated greater cognitive impairment than those with lower 
levels of burden. Level of neurocognitive burden was also a significant predictor of 
performance in all individual domains of cognition examined, including verbal learning 
and memory, selective attention, and sustained attention and working memory. These 
findings are consistent with previous literature examining the aggregate effects of 
multimorbid risk factors on cognitive functioning (Patel et al., 2013). 
Although we would expect those with a history of moderate to severe TBI to 
demonstrate greater cognitive dysfunction, while controlling for the level of 
neurocognitive burden, this was not shown to be the case. TBI was not found to be a 
significant predictor of composite cognition, regardless of the level of neurocognitive 
burden. Furthermore, it was expected that the impact of history of TBI on cognition 
would be greater in persons with higher levels of neurocognitive burden (i.e. those with a 
history of TBI and high burden would show larger cognitive deficits than those with a 
history of TBI and low neurocognitive burden), however the TBI by neurocognitive 
burden interaction term did not account for a significant amount of the variance in 
composite cognition. These findings were consistent across the individual cognitive 
domains of verbal learning and memory, selective attention, and sustained attention and 
working memory. These findings indicate that self-reported TBI history may have 
minimal value in signifying cognitive dysfunction in multimorbid marginally housed 
individuals.  
Although counter to our hypotheses, the lack of interaction between 
neurocognitive burden and TBI falls in line with some previous research by Dikmen and 
colleagues (1993) examining whether preinjury history of alcohol abuse exacerbates the 
neuropsychological deficits associated with mild to severe head trauma. Researchers 
found no evidence of a greater effect of head injury in those with greater alcohol 
problems, despite neuropsychological outcome being significantly related to both head 
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injury severity and prior alcohol use. Similarly, a study by Wilde and colleagues (2004) 
examining the effects of alcohol abuse and TBI on brain atrophy and neuropsychological 
outcome found patients with a history of moderate to heavy alcohol use to have 
increased general brain atrophy, but no significant difference in cognition, compared to 
non-alcohol abusing TBI patients. 
Supplemental analyses compared the predictive power of different domains of 
risk factors for neurocognitive burden (i.e. demographics, cognitive reserve, mental 
illness, viral infection, vascular health, neurological illness) and TBI on composite 
cognition. Again, cognitive reserve was found to be the strongest predictor of 
neurocognition. In order of greatest to weakest influence, mental illness, older age, and 
poor vascular health were found to be associated with cognitive dysfunction. Viral 
infection, neurological illness, and history of TBI did not predict neurocognition. These 
findings suggest that in multimorbid marginally housed individuals, non-TBI risk factors 
including cognitive reserve, mental illness, age, and vascular health, are better 
predictors of cognitive dysfunction and may be the most influential treatment foci in this 
complex population. 
5.2. Limitations and Future Research 
First, this study relied on a self-report measure for information on the presence 
and severity of past traumatic brain injury. In a subset of individuals, the measure used 
(i.e. MRQ) was found to have fair convergence with another interviewer administered 
self-report measure (i.e. BISQ) given to a subset of individuals (Landis & Koch, 1977). 
Although the MRQ was able to correctly identify almost all of those with reported TBIs, 
some participants were classified as having no TBI on the MRQ when they reported an 
injury on the BISQ. Although this calls into question the validity of the control group in 
this study, the analysis was re-run using the BISQ classification and there was no 
change in results. Similarly, when the control group included those with no reported TBI 
on both the MRQ and the BISQ there was no change in results. 
As both the MRQ and BISQ were interviewer-administered self-report measures 
of traumatic brain injury, these methods may have been susceptible to response styles, 
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lack of insight, and recall errors due to cognitive deficits. In a study by Sherer et al. 
(2015), researchers found that individuals with medically verified history of TBI reported 
longer periods of loss of consciousness and posttraumatic amnesia than indicated on 
medical records. This was especially true for individuals with lower cognitive functioning 
and longer time since injury. To examine the validity of self-reported traumatic brain 
injury in this sample, the effect of objective TBI as determined by MRI on cognition was 
examined. Findings were congruent whether traumatic brain injury was defined from 
self-report or magnetic resonance imaging. Thus, findings do not appear to be a function 
of the method that information was obtained. However, it is possible that some 
individuals may have been unaware of their own history of brain injury, or failed to report 
it, yet showed no signs of past traumatic brain injury on brain imaging measures. This 
would have allowed them to be included in the control group of the study. Inadvertently 
classifying participants incorrectly could have resulted in a smaller sample size of 
individuals in the traumatic brain injury group, resulting in lower power to detect the 
effect of TBI on cognition, which would also be wrongly skewed. Given the logistical 
difficulties inherent in using self-reported history of brain injury in a marginalized 
population, future studies may benefit from using self-report measures of TBI proximal to 
the incident, and follow individuals longitudinally to determine the acute effects and 
recovery from TBI in this complex multimorbid sample.  
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Appendix A 
Participant Flow Chart 
 
 
Enrolled in the study 
n = 374 
Valid MRI scan 
n = 275 
• Missing or invalid MRI scan,
n = 55
Valid & complete data for creation 
of cognitive composite 
n = 332 
• Missing or invalid data on more
than 1 cognitive measure,
n = 42
Member of control / experimental 
group 
n = 220 
• Otherwise controls with MRI
defined TBI, n = 9
• Reported mild TBI, n = 36
• TBI with unknown LOC/PTA,
n = 10
No TBI 
n = 171 
Mod/Sev TBI 
n = 49 
Complete head/face injury data 
n = 330 
• Missing injury report data,
n = 2
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Appendix B. 
Medical Review Questionnaire 
This questionnaire was used as a screening tool for traumatic brain injury. Question 8 A 
to F contains all relevant questions pertaining to possible head or face injury. 
Past Medical History: 
INTERVIEWER: First we want to discuss any health issues you may have had in the past. 
1) Did you have any health
problems as a child/while
growing up?
 NO
 YES   ➡
IF “YES”, PLEASE HAVE PARTICIPANT SPECIFY: 
____________________________
____________________________
____________________________ 
2) In school, were you ever told
you had a learning
disability?
 NO
 YES   ➡
Were you ever in special education 
classes? 
 NO
 YES
3) Were you ever diagnosed with anything like:
a) Attention Deficit Disorder
 NO
 YES
b) Dyslexia
 NO
 YES
c) Eating problems
 NO
 YES ➡
Anorexia 
 NO
 YES
Bulimia 
 NO
 YES
4) Have you ever been in the hospital because of
serious illness in the past?
 NO (PROCEED TO Q5)
 YES (PROCEED TO Q4a)
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a) Have you ever had surgery?
 No
(PROCEED TO Q4b) 
 Yes ➡
What type of surgery was it? 
 OPEN-HEART
 TO CLEAR ARTERIES TO THE
BRAIN
 ABDOMINAL
 OTHER_________________
Were you 
under general 
anesthetic? 
 NO
 YES   ➡
How long were you 
unconscious? 
 < 1hr
 > 1hr
b) Have you ever had a heart
attack/heart disease?
 NO
 YES   ➡
Have you ever been resuscitated? 
 NO
 YES
5. Have you ever had a heart
murmur or a problem with
your heart valves?
 NO
 YES
6. Have you ever had
cancer?
 NO
 YES ➡
Type When Treatment 
1.  Chemotherapy
 Radiation
 Surgery
2.  Chemotherapy
 Radiation
 Surgery
7. Have you ever had:
a) Pneumonia
 NO
 YES
b) Asthma
 NO
 YES
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c) Emphysema
 NO
 YES
d) Bronchitis
 NO
 YES
Current Medical Conditions
INTERVIEWER: Now we want to discuss any health issues that may be affecting you right now.
1. Do you have any allergies?
 NO
 YES
2. In general, do you have any problems
sleeping?
 NO
 YES
3. Do you get regular exercise?
 NO
 YES
4. Has your weight changed lately?
 NO
 YES  ➡
A) By how much has your weight changed?
___________________________
5. Do you frequently have to stay in bed
because of illness?
 NO
 YES
INTERVIEWER: Now we’ll go through the body from the head down to find out about any problems. 
6. Do you have any problems with:
a) Your vision
 NO
 YES  ➡
Do you have: 
Trouble with your vision that prevents you from 
reading ordinary print even when you have glasses 
on 
 NO
 YES
Glaucoma 
 NO
 YES
Cataracts  NO
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 YES
b) Your hearing
 NO
 YES  ➡
Do you have a hearing aid? 
 NO
 YES
7. Have you ever had/do you have problems with:
a) Your sinuses
 NO
 YES
b) Headaches
 NO
 YES
c) Dizziness or fainting
 NO
 YES
d) Seizures, fits or Epilepsy
 NO
 YES  ➡
Date of most recent? 
___________ 
For how long do the seizures or 
fits last? 
(MARK ALL THAT APPLY) 
 Seconds
 Minutes
 Hours
 Days
Have you ever been treated for 
Epilepsy? 
 NO
 YES
e) Your memory
 NO
 YES  ➡
Dementia 
 NO
 YES
Alzheimer’s Disease 
 NO
 YES
f) A stroke
 NO
 YES
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8. Have you ever had a serious head/face injury?
 NO (PROCEED TO Q.9)
 YES   ➡
a) What was your age at the time of the injury?
IF SUBJECT ENDORSES MORE THAN ONE 
INCIDENT REPORT MOST SEVERE. 
_____ YEARS OLD 
b) Please describe the event that caused injury:
_________________________ 
_________________________
Please explain what the injury was: 
____________________________
____________________________ 
c) Did you lose consciousness?  NO
 YES   ➡
For how long? 
_____________ 
 Seconds
 Minutes
 Hours
 Days
d) Were you hospitalized for this
injury?
 NO
 YES   ➡
Where? ________________________ 
For how long? ____________________
e) Did you have dizziness, headache,
blurred vision, or other problems
relating to the injury?
 NO
 YES   ➡
For how long? __________________
f) Did you suffer from confusion or
loss of memory?
 NO
 YES   ➡
9. Do you have problems with your
metabolism, such as Thyroid
problems, Diabetes or High
Cholesterol?
 NO
 YES   ➡
Thyroid 
 NO
 YES
Diabetes 
 NO
 YES
High Cholesterol 
 NO
 YES
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10. Do you have any
problems with your
chest/lungs?
 NO
 YES  ➡
Are you ever 
short of 
breath? 
 NO
 YES  ➡
Do you experience 
shortness of breath when 
you are sitting still? 
 NO
 YES
b) Do you use home oxygen?
 NO
 YES
11. INTERVIEWER: Now I’m going to ask some questions about heart problems. Do you have any:
a) Chest pain
 NO
 YES
b) Blood pressure problems
 NO
 YES   ➡
 High blood pressure
 NO
 YES
 Low blood pressure
 NO
 YES
12. Any problems with your
digestion or bowels?
 NO
 YES
13. Any problems with your
liver?
 NO
 YES
14. Any problems with your
bladder or kidneys?
 NO
 YES ➡
Are you receiving kidney 
dialysis? 
 NO
 YES
15. Any problems with your
bones or joints?
 NO
 YES ➡
 Arthritis
 NO
 YES ➡
How severe is your 
Arthritis?  
 Mild
 Moderate
 Moderate-severe
 Severe
 Osteoporosis
 NO
 YES
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 Back pain that
interferes with your
everyday functions
 NO
 YES
16. Do you have varicose veins in your legs?
 NO
 YES
17. INTERVIEWER: Finally, I want to ask you about infections. Have you ever had/do you have:
a) Scarlet/
Rheumatic Fever
 NO
 YES
b) Tuberculosis
 NO
 YES
c) An MRSA
infection
 NO
 YES
d) HIV
 NO   ➡
Have you ever been 
tested for HIV? 
 NO
 YES  ➡
First test date: ___________ 
Most recent test date: _______ 
 YES  ➡ What date did you test positive? ___________________________ 
e) Hepatitis
 NO   ➡ Have you ever been 
tested for Hepatitis? 
 NO
 YES  ➡
First test date (Hep A): _____
Most recent test date (Hep A): 
___________________
First test date (Hep B): _____
Most recent test date (Hep B): 
___________________
First test date (Hep C): _____
Most recent test date (Hep C): 
___________________
 YES  ➡  Hep A  ➡ What date did you test positive? _______________ 
44 
 Hep B  ➡ What date did you test positive? _______________ 
 Hep C  ➡ What date did you test positive? _______________ 
f) Meningitis or
Encephalitis 
 NO
 YES  ➡
Age of 
infection: ____ 
Were you 
hospitalized? 
 NO
 YES ➡
Which Hospital? 
_______________ 
For how long? 
_______________ 
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Appendix C. 
Traumatic brain injury and all risk factors for 
neurocognitive burden included in screening of their 
impact on composite cognition 
Effect sizes marked with an asterisk denotes those with a d of at least 0.2 in the 
appropriate direction (i.e. negatively associated with cognition); risk factors for 
neurocognitive burden with an asterisk were included in the neurocognitive burden 
index. 
Variable Description Effect 
Size 
(d) 
Coding 
Traumatic Brain Injury 
TBI Self-report measure with controls 
verified by MRI 
-.019 [0,1] where no MRI verified 
history of TBI, and either no 
reported head/face injury, 
injury with no symptoms, or 
possible TBI = 0, reported 
history of moderate/severe 
TBI = 1 
Demographic Variables 
Age Age in years -.398* Continuous variable 
Cognitive reserve Composite of reading ability and 
years of education attained 
-.863* Continuous variable made 
into negative association with 
cognition 
Vascular Health Variables 
History of Stroke Ever had stroke -.161 [0,1] where no history = 0, 
history = 1 
Cholesterol Level Current low versus high cholesterol 
level 
-.046 [0,1] where low (less than or 
equal to 5 mmol) = 0, high 
(greater than 5 mmol) = 1 
History of Heart 
Attack/Disease 
Ever had a heart attack or heart 
disease 
-.305* [0,1] where no history = 0, 
history = 1 
History of Diabetes Ever had diabetes -.584* [0,1] where no history = 0, 
history = 1 
Pulse Pressure At risk for cardiovascular disease 
versus normal levels 
.191 [0,1] where normal (less than 
60) = 0, at risk (60 or higher)
=1
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Variable Description Effect 
Size 
(d) 
Coding 
Body Mass Index Obese versus normal/overweight 
index 
.026 [0,1] where normal or 
overweight (less than 30) = 
0, obese (30 or higher) = 1 
Substance Dependence Variables 
Alcohol dependence Diagnosed using the BECED 
according to DSM-IV criteria 
-.056 [0,1] where diagnosis absent 
= 0, present = 1 
Cocaine dependence Diagnosed using the BECED 
according to DSM-IV criteria 
-.067 [0,1] where diagnosis absent 
= 0, present = 1 
Methamphetamine 
dependence 
Diagnosed using the BECED 
according to DSM-IV criteria 
.117 [0,1] where diagnosis absent 
= 0, present = 1 
Heroin dependence Diagnosed using the BECED 
according to DSM-IV criteria 
.212 [0,1] where diagnosis absent 
= 0, present = 1 
Methadone dependence Diagnosed using the BECED 
according to DSM-IV criteria 
.040 [0,1] where diagnosis absent 
= 0, present = 1 
Cannabis dependence Diagnosed using the BECED 
according to DSM-IV criteria 
.047 [0,1] where diagnosis absent 
= 0, present = 1 
Mental Illness Variables 
Depression Diagnosed using the BECED 
according to DSM-IV criteria 
-.194 [0,1] where diagnosis absent 
= 0, present = 1 
Schizophrenia Diagnosed using the BECED 
according to DSM-IV criteria 
-.557* [0,1] where diagnosis absent 
= 0, present = 1 
Schizoaffective Disorder Diagnosed using the BECED 
according to DSM-IV criteria 
.464 [0,1] where diagnosis absent 
= 0, present = 1 
Bipolar I Disorder Diagnosed using the BECED 
according to DSM-IV criteria 
.551 [0,1] where diagnosis absent 
= 0, present = 1 
Psychosis Not 
Otherwise Specified 
Diagnosed using the BECED 
according to DSM-IV criteria 
-.347* [0,1] where diagnosis absent 
= 0, present = 1 
Viral Infection Variables 
HIV Human immunodeficiency virus -.290* [0,1] where antibody negative 
= 0, positive = 1 
HepB Hepatitis B virus -.311* [0,1] where antibody negative 
= 0, positive = 1 
HepC Hepatitis C virus -.146 [0,1] where antibody negative 
= 0, positive = 1 
CMV Cytomegalovirus -.055 [0,1] where antibody negative 
= 0, positive = 1 
HSV Herpes simplex virus -.164 [0,1] where antibody negative 
= 0, positive = 1 
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Variable Description Effect 
Size 
(d) 
Coding 
Neurological Illness Variables 
Lesion/Trauma due to 
Infection 
Based off of MRI reading -.317* [0,1] where no lesion/trauma 
= 0, present = 1 
Stroke with Hemorrhage Based off of MRI reading -.241* [0,1] where no hemorrhage = 
0, present = 1 
Hemorrhage not due to 
stroke 
Based off of MRI reading .588 [0,1] where no hemorrhage = 
0, present = 1 
Infarct Based off of MRI reading .010 [0,1] where no infarct = 0, 
present = 1 
Lacune Based off of MRI reading -.281* [0,1] where no lacune = 0, 
present = 1 
